We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
576
United Therapeutics
UTHR
$26.3B
$32.9M 0.04%
118,310
-8,281
-7% -$2.09M
SKX
577
DELISTED
Skechers
SKX
$32.9M 0.04%
784,058
-40,439
-5% -$1.55M
PACB icon
578
Pacific Biosciences
PACB
$422M
$32.8M 0.04%
4,012,524
-10,748
-0.3% -$92.6K
IR icon
579
Ingersoll Rand
IR
$33B
$32.7M 0.04%
625,946
-27,546
-4% -$1.41M
FIVE icon
580
Five Below
FIVE
$11.2B
$32.6M 0.04%
184,543
+19,203
+12% +$3.02M
INVH icon
581
Invitation Homes
INVH
$17.7B
$32.4M 0.04%
1,094,416
-269,249
-20% -$8.53M
CSX icon
582
CSX Corp
CSX
$98.6B
$32.3M 0.04%
1,049,013
+98,395
+10% +$2.96M
AORT icon
583
Artivion
AORT
$1.23B
$32.3M 0.04%
2,662,637
+68,616
+3% +$824K
MAR icon
584
Marriott International
MAR
$98.7B
$31.9M 0.04%
214,258
+5,683
+3% +$875K
JACK icon
585
Jack in the Box
JACK
$278M
$31.9M 0.04%
466,925
-2,853
-0.6% -$219K
DV icon
586
DoubleVerify
DV
$1.62B
$31.7M 0.04%
1,444,232
+637,017
+79% +$16.6M
ATI icon
587
ATI
ATI
$27B
$31.5M 0.04%
1,056,557
+20,125
+2% +$589K
WEC icon
588
WEC Energy
WEC
$37.7B
$31.5M 0.04%
337,131
+8,595
+3% +$794K
MRO
589
DELISTED
Marathon Oil Corporation
MRO
$31.3M 0.04%
1,154,852
-41,748
-3% -$1.21M
OVV icon
590
Ovintiv
OVV
$17.5B
$31.2M 0.04%
614,931
+6,875
+1% +$359K
DHI icon
591
D.R. Horton
DHI
$41B
$31.1M 0.04%
349,006
-9,886
-3% -$792K
EVH icon
592
Evolent Health
EVH
$475M
$31.1M 0.04%
1,106,832
-347,864
-24% -$9.97M
SNPS icon
593
Synopsys
SNPS
$71.5B
$31M 0.04%
97,026
+1,654
+2% +$518K
HPQ icon
594
HP
HPQ
$23.5B
$30.9M 0.04%
1,150,782
+5,998
+0.5% +$166K
HYG icon
595
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$30.9M 0.04%
419,000
SBUX icon
596
Starbucks
SBUX
$118B
$30.8M 0.04%
310,865
+99,569
+47% +$9.4M
BURL icon
597
Burlington
BURL
$22B
$30.8M 0.04%
151,855
-12,471
-8% -$1.99M
STT icon
598
State Street
STT
$50.9B
$30.8M 0.04%
396,587
-55,277
-12% -$4.07M
BHP icon
599
BHP
BHP
$213B
$30.6M 0.04%
492,868
+21,377
+5% +$1.2M
VEEV icon
600
Veeva Systems
VEEV
$30.3B
$30.5M 0.04%
188,771
+139,336
+282% +$23.8M

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.